OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
Graciela Argüello, Elisa Balboa, Marco Arrese, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2015) Vol. 1852, Iss. 9, pp. 1765-1778
Open Access | Times Cited: 285

Showing 1-25 of 285 citing articles:

Per‐ and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
Suzanne E. Fenton, Alan Ducatman, Alan R. Boobis, et al.
Environmental Toxicology and Chemistry (2020) Vol. 40, Iss. 3, pp. 606-630
Open Access | Times Cited: 1261

Triggering and resolution of inflammation in NASH
Susanne Schuster, Daniel Cabrera, Marco Arrese, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 6, pp. 349-364
Closed Access | Times Cited: 726

Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
Juan Pablo Arab, Marco Arrese, Michael Trauner
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 13, Iss. 1, pp. 321-350
Open Access | Times Cited: 476

Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
Manoela Mota, Bubu A. Banini, Sophie C. Cazanave, et al.
Metabolism (2016) Vol. 65, Iss. 8, pp. 1049-1061
Open Access | Times Cited: 472

Innate Immunity and Inflammation in NAFLD/NASH
Marco Arrese, Daniel Cabrera, Alexis M. Kalergis, et al.
Digestive Diseases and Sciences (2016) Vol. 61, Iss. 5, pp. 1294-1303
Open Access | Times Cited: 431

The Role of Cholesterol in the Pathogenesis of NASH
George N. Ioannou
Trends in Endocrinology and Metabolism (2015) Vol. 27, Iss. 2, pp. 84-95
Closed Access | Times Cited: 421

Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment
Meric Erikci Ertunc, Gökhan S. Hotamışlıgil
Journal of Lipid Research (2016) Vol. 57, Iss. 12, pp. 2099-2114
Open Access | Times Cited: 420

Animal models for liver disease – A practical approach for translational research
Yulia A. Nevzorova, Zoé Boyer-Díaz, Francisco Javier Cubero, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 423-440
Open Access | Times Cited: 189

The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background
Jinsheng Yu, Sharon Marsh, Junbo Hu, et al.
Gastroenterology Research and Practice (2016) Vol. 2016, pp. 1-13
Open Access | Times Cited: 185

FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
Erik J. Tillman, Timothy P. Rolph
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 161

Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis
Heng Li, Xiao-Hua Yu, Xiang Ou, et al.
Progress in Lipid Research (2021) Vol. 83, pp. 101109-101109
Closed Access | Times Cited: 145

The Bioavailability and Biological Activities of Phytosterols as Modulators of Cholesterol Metabolism
Xiang Li, Yan Xin, Yuqian Mo, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 523-523
Open Access | Times Cited: 108

Microalgae—Sustainable Source for Alternative Proteins and Functional Ingredients Promoting Gut and Liver Health
Yahav Eilam, Hamdan Khattib, Noam Pintel, et al.
Global Challenges (2023) Vol. 7, Iss. 5
Open Access | Times Cited: 45

Submicron Dispersions of Phytosterols Reverse Liver Steatosis with Higher Efficacy than Phytosterol Esters in a Diet Induced-Fatty Liver Murine Model
Raimundo Gillet, Tomás G. Cerda-Drago, María C. Brañes, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 564-564
Open Access | Times Cited: 2

Intake of stigmasterol and β-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet
Simin Feng, Zhuqing Dai, Anna B. Liu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2018) Vol. 1863, Iss. 10, pp. 1274-1284
Open Access | Times Cited: 149

New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
Nahúm Méndez‐Sánchez, Vania Cruz-Ramón, Oscar Ramírez-Pérez, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 2034-2034
Open Access | Times Cited: 140

Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease
Milena Vesković, Dušan Mladenović, Marina Milenković, et al.
European Journal of Pharmacology (2019) Vol. 848, pp. 39-48
Closed Access | Times Cited: 128

Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis
Francesco Bellanti, Rosanna Villani, Antonio Facciorusso, et al.
Free Radical Biology and Medicine (2017) Vol. 111, pp. 173-185
Closed Access | Times Cited: 115

Role of Natural Phenolics in Hepatoprotection: A Mechanistic Review and Analysis of Regulatory Network of Associated Genes
Priyanka Saha, Anupam Das Talukdar, Rajat Nath, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 115

Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver
Rohitash Jamwal, Suzanne M. de la Monte, K. OGASAWARA, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 7, pp. 2621-2632
Open Access | Times Cited: 107

Pathogenesis of NASH: the Impact of Multiple Pathways
Mazen Noureddin, Arun J. Sanyal
Current Hepatology Reports (2018) Vol. 17, Iss. 4, pp. 350-360
Open Access | Times Cited: 107

Phytosterols and their derivatives: Potential health‐promoting uses against lipid metabolism and associated diseases, mechanism, and safety issues
Simin Feng, Tarun Belwal, Li Li, et al.
Comprehensive Reviews in Food Science and Food Safety (2020) Vol. 19, Iss. 4, pp. 1243-1267
Open Access | Times Cited: 104

A sulfated polysaccharide fromGracilaria Lemaneiformisregulates cholesterol and bile acid metabolism in high-fat diet mice
Shiming Huang, Daorui Pang, Li Xiong, et al.
Food & Function (2019) Vol. 10, Iss. 6, pp. 3224-3236
Closed Access | Times Cited: 98

The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids
Sebastian Prill, Andrea Caddeo, Guido Baselli, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 97

Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Chanbin Lee, Ji‐Eun Kim, Youngmi Jung
Cells (2019) Vol. 8, Iss. 10, pp. 1259-1259
Open Access | Times Cited: 97

Page 1 - Next Page

Scroll to top